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ABSTRACT
Background: The present study aimed to illustrate clinical characteristics of spirometric measures and allergy
sensitisation among young atopic adults who reported wheezing episodes before adulthood but were not diag-
nosed with asthma by physicians and have no current wheeze symptoms (self-reported past-wheezers), espe-
cially those who exhibited airway hyperresponsiveness (AHR).
Methods: Fifty self-reported past-wheezers were divided into two groups according to AHR to methacholine.
Spirometric functions and blood atopic parameters were compared in these groups with those in 25 age-
matched atopic adults with a history of childhood asthma diagnosed by specialists but have no current wheeze
symptoms (past-asthmatics) and in 60 counterparts without a previous and current wheezing episode (never-
wheezers).
Results: Twenty-one of the 50 past-wheezers exhibited AHR (PC20 <8 mgml). Levels of spirometric function
and allergic sensitization in both past-wheezer groups were intermediate between those in never-wheezers and
past-asthmatics. Lower FEV1 and FEF25-75 values (% predicted) were observed in self-reported past-wheezers
with AHR relative to those without AHR. More blood eosinophils and higher serum levels of total IgE and IgE
specific to house dust mites were observed in self-reported past-wheezers with AHR relative to those without
AHR.
Conclusions: Our findings raise the possibility that self-reported past-wheezers with AHR might form a dis-
tinct subgroup with features similar to past-asthmatics, which is one of the risk groups for adult asthma.
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INTRODUCTION
Asthma is a clinical syndrome that is generally diag-
nosed according to a history of respiratory symptoms
and objective measurements of lung function and air-
way inflammation.1 In particular, wheezing is a char-
acteristic symptom that is used for diagnosis, along
with coughing and chest tightness. However, the na-
ture of wheezing disorders varies among individuals,
particularly during childhood.2 Early-life wheezing ill-
ness among preschool children can be characterised
into distinct subtypes (transient early, late-onset or
persistent) based on the symptom history.3 Further-
more, such wheezing types early in life are thought to
determine the expression of asthma and the level of
lung function later in life.4-6 Similarly, wheezing
symptoms may emerge during adolescence, even in
atopic individuals who did not experience any wheez-
ing episodes during preschool,7 and the lung growth
(assessed by FEV1) is known to be reduced.8 These
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Fig.　1　Study profi le. A fl ow chart indicating the number of subjects recruited to 
the study and their subsequent participation and subject classifi cation. Never-
wheezers, subjects with no past history of wheezing symptoms; Self-reported past-
wheezers, subjects with a childhood/adolescent history of wheezing symptoms but 
without an asthma diagnosis; Past-asthmatics, subjects who had a history of asth-
ma at their school-ages diagnosed by pediatric specialists but had no wheeze 
symptoms without use of any asthma medication for at least 3 preceding years.
260 University students
recruited
(Never smokers)
60
Never-wheezers
50
Self-reported
past-wheezers
25
Past-asthmatics
Preliminary assessment 
questionnaire, physical examination and blood sampling
21 AHR (+)29 AHR (-)
135 Atopic subjects 
without current respiratory symptoms and signs
who agreed with participation and 
completed preliminary assessment
Methacholine test
Based on the past history
links between childhoodadolescent respiratory
symptoms and subsequent outcomes can be ob-
served even in asymptomatic adults.9
A subset of young atopic adults without current
respiratory symptoms present with a history of
wheezing from early infancy through adolescence but
were not diagnosed with asthma by a physician (re-
ferred to as self-reported past-wheezers). They often
attribute their previous wheezing symptoms to a bad
cold. In contrast, almost half of young atopic adults
previously diagnosed with childhood asthma no
longer have respiratory symptoms (referred to as
past-asthmatics).10,11 They often consider themselves
to be grown out of their disease at the stage of young
adulthood.12 Despite the remission of symptoms,
however, these past-asthmatics are known to have oc-
cult impairment in pulmonary function, such as that
assessed by FEV1 and FEF25-75,9,12-14 and higher lev-
els of specific IgE to house dust mite in past-
asthmatics were observed than in young atopic adults
who have no history of asthma.15 Until now, the simi-
larities and differences in spirometric measures and
allergy sensitisation among self-reported past-
wheezers, past-asthmatics and age-matched young
atopic adults with no history of wheezing (referred to
as never-wheezers) have not been fully described.
Furthermore, it is also unknown whether the physi-
ological and serological characteristics of self-
reported past-wheezers are related to the presence or
absence of airway hyperresponsiveness (AHR). Previ-
ous longitudinal studies have demonstrated that, in
children and young adults who have had ‘recent’
wheezing episodes within the previous 12 months,
the coexistence of AHR represents a clinically rele-
vant disease entity that is associated with asthma, in-
cluding lower lung function.7,8,16
The objective of the present study was to compare
spirometric measures and allergy sensitisation in
young atopic adult self-reported past-wheezers with
or without AHR, to those in past-asthmatics and age-
matched atopic never-wheezers. Examining these dif-
ferences might help us characterise young atopic
adult self-reported past-wheezers, evaluate the impor-
tance of identifying self-reported past-wheezers in
clinical settings, and delineate a part of the natural
history of asthma-related wheezing phenotypes at the
stage of young adulthood.
METHODS
Subjects were recruited randomly from a list of uni-
Self-Reported Past Wheeze, AHR and Atopy
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Table 1　Characteristics of all subjects
Subjects
without past history of
wheeze
(Never-wheezers)
(n = 60)
Subjects with past history of wheeze
(Self-reported past-wheezers)
Subjects
with remission of
asthma
(Past-asthmatics)
(n = 25)
P valuewithout AHR
(PC20 ≥8 mg/mL)
(n = 29)
with AHR
(PC20 <8 mg/mL)
(n = 21)
Age [years] 19 (18-20) 19 (18-20) 19 (18-20) 19 (19-20) 0.624
Sex [M/F] 19/41 14/15 8/13 7/18 0.373
BMI [kg/m2] 20.7 (19.6-22.1) 20.8 (19.5-21.8) 21.0 (19.7-21.7) 20.2 (18.7-20.9) 0.515
Allergic Rhinitis [%] 56.7 62.1 71.4 76.0 0.321
Atopic dermatitis [%] 22.9 14.3 25.0 21.1 0.849
Age and BMI were not normally distributed and presented as median (25 and 75 percentile).
These values for the volunteer groups were compared by Kruskal-Wallis one-way analysis of variance on ranks.
Categorical data for the volunteer groups were compared by chi-square test.
No signifi cant differences among the subject groups were observed in these parameters.
During methacholine testing, subjects inhaled saline (baseline) or methacholine solution (0.3-16 mg/mL) for 2 min by tidal breathing.
Of the 50 self-reported past-wheezers, 21 (42.0%) exhibited signifi cant AHR (PC20 2.3 to 5.0 mg/mL (25th to 75th percentile); median 3.6 
mg/mL).
All subjects (n = 135) are life-long non-smokers.
BMI, body mass index; AHR, airway hyperresponsiveness.
versity students, and only individuals who had never
smoked were asked to participate in the study (Fig.
1). All of the participants were asked to complete
questionnaires that examined their past and current
experience of the following events: respiratory symp-
toms including wheezing episodes, diagnosed
asthma, other respiratory illness, allergic diseases,
and medication use. All participants underwent physi-
cal examinations, including body mass index (BMI),
and blood sampling. Only individuals who met at
least one of the following criteria were included in the
present study as atopic subjects: 1) current or past
history of allergic diseases, such as hay fever and
atopic dermatitis, that had been diagnosed by special-
ists; 2) total serum immunoglobulin E (IgE) levels of
more than 250 IUmL; or 3) one or more specific IgE
levels of more than 0.34 UamL to common aeroaller-
gens, including house dust mites, animal dander, and
cedar pollen, as determined by a radioallergosorbent
test (RAST) using UniCAP IgE fluoroenzyme immu-
noassays (Sweden Diagnostics, Uppsala, Sweden).
The following three groups of study subjects were
then classified, based on self-reported information: 1)
those with no past history of wheezing symptoms
(never-wheezers), 2) those with a history of wheezing
symptoms during childhood who had never been di-
agnosed with asthma (self-reported past-wheezers)
and 3) those who had a history of asthma at their
school-ages diagnosed by pediatric specialists but
had no wheeze symptoms without use of any asthma
medication for at least 3 preceding years (past-
asthmatics).17 The self-reported past-wheezers were
further divided into two groups (with or without
AHR) according to their airway response to meth-
acholine exposure.
A spirometer (Chestac-25F; Chest Co., Tokyo, Ja-
pan) was used to obtain all of the spirometric meas-
urements (FEV1, FVC, FEV1FVC and FEF25-75). For
all of the self-reported past-wheezers, the meth-
acholine provocation test was performed as recom-
mended by the American Thoracic Society (ATS)
guidelines.18 Briefly, the subjects inhaled saline
(baseline) or methacholine solution (0.3-16 mgmL)
for 2 min by tidal breathing from a Devilbiss 646
nebuliser (Devilbiss Co., Somerset, PA, USA) oper-
ated with compressed air at 5 Lmin. Spirometry was
performed approximately 30 seconds after each inha-
lation, and the FEV1 was measured. These measured
values were plotted on a semilogarithmic graph, and
the concentration of methacholine that was able to
provoke a 20% drop in FEV1 (PC20) was calculated in
noncumulative units by linear interpolation between
the last two points on the graph. If the PC20 was <8
mgmL, the subject was categorised as having AHR.
All visits were conducted outside the pollen season in
subjects with seasonal allergic symptoms.
All of the statistical analyses were performed using
SPSS ver.18 for Windows (SPSS Inc., Chicago, IL,
USA). Results are expressed as medians (25th and 75
th percentiles). However, the spirometric data, which
were normally distributed, are presented as mean ±
SD. Serum total IgE levels were transferred to a loga-
rithmic function to yield normally skewed data during
the analyses. The age, BMI, blood eosinophils and se-
rum specific IgE levels of subject groups were com-
pared using the nonparametric Kruskal-Wallis test.
The Mann-Whitney U-test was performed for com-
parison between two subject groups after the
Kruskal-Wallis test when appropriate. The spiromet-
ric data and the log values of serum total IgE of sub-
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Fig.　2　Mean values of FEV1 (A) and FEF25-75 (B)(% predicted), obtained from never-
wheezers, self-reported past-wheezers both without AHR and with AHR and past-asth-
matics in young atopic adults who are currently asymptomatic. These spirometric param-
eters were signifi cantly lower in the past-asthmatics than in never-wheezers and self-
reported past-wheezers without AHR. And the self-reported past-wheezers with AHR had 
reduced spirometric function compared with those without AHR. Never-wheezers, sub-
jects with no past history of wheezing symptoms; Self-reported past-wheezers, subjects 
with a childhood/adolescent history of wheezing symptoms but without an asthma diagno-
sis; Past-asthmatics, subjects who had a history of asthma at their school-ages diag-
nosed by pediatric specialists but had no wheeze symptoms without use of any asthma 
medication for at least 3 preceding years; AHR, airway hyperresponsiveness.
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Fig.　3　Blood eosinophil counts (per mm3) obtained from never-wheezers, self-reported 
past-wheezers both without AHR and with AHR and past-asthmatics in young atopic adults 
who are currently asymptomatic. The horizontal bars represent the median values for each 
subject group. Higher eosinophil counts were observed in past-asthmatics than in never-
wheezers and self-reported past-wheezers without AHR. Similarly, the self-reported past-
wheezers with AHR had increased numbers of eosinophils compared with those without 
AHR and never-wheezers. Never-wheezers, subjects with no past history of wheezing 
symptoms; Self-reported past-wheezers, subjects with a childhood/adolescent history of 
wheezing symptoms but without an asthma diagnosis; Past-asthmatics, subjects who had 
a history of asthma at their school-ages diagnosed by pediatric specialists but had no 
wheeze symptoms without use of any asthma medication for at least 3 preceding years; 
AHR, airway hyperresponsiveness.
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ject groups were compared using the one-way analy-
sis of variance (ANOVA) followed by Holm-Sidak
post-hoc test. The categorical data was compared
among subject groups using chi-squared tests. P-
values less than 0.05 were considered statistically sig-
nificant. The study project was approved by our local
ethics committee, and all of the subjects signed an in-
formed consent form and the subject anonymity was
preserved using documents and methods approved
by the ethical committee. All of the procedures were
performed in accordance with the research ethics de-
fined in the Declaration of Helsinki.19
RESULTS
Sixty never-wheezers (19 males, 41 females; aged 18
to 20 yrs), 50 self-reported past-wheezers (22 males,
28 females; aged 18 to 20 yrs) and 25 past-asthmatics
(7 males, 18 females; aged 19 to 20 yrs) participated
in the study (Fig. 1). Table 1 presents the back-
ground information on the subjects. No significant
differences were observed among four subject
groups in BMI, prevalence of allergic rhinitis and
atopic dermatitis. Of the 50 self-reported past-
wheezers, 21 (42.0%) exhibited significant AHR (PC20
2.3 to 5.0 mgmL (25th to 75th percentile); median
3.6 mgmL).
The mean baseline FEV1 and FEF25-75 (% pre-
dicted) values were lower in past-asthmatics com-
pared with never-wheezers and self-reported past-
wheezers without AHR (FEV1; P = 0.003 by one-way
ANOVA, P = 0.020 vs. never-wheezers and P < 0.001
vs. self-reported past-wheezers without AHR by post-
hoc test, FEF25-75; P = 0.027 by one-way ANOVA, P =
0.029 vs. never-wheezers and P = 0.004 vs. self-
reported past-wheezers without AHR by post-hoc test,
respectively) (Fig. 2A, 2B). In addition, these spi-
rometric parameters were lower in self-reported past-
wheezers with AHR compared with those without
AHR (FEV1, P = 0.025; FEF25-75, P = 0.05 by post-hoc
test). The FVC and FEV1FVC values were not sig-
nificantly different among the subject groups (data
not shown).
The blood eosinophil counts were significantly
higher in past-asthmatics compared with never-
Yoshikawa T et al.
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Fig.　4　Mean values of total serum IgE levels obtained from never-wheezers, self-report-
ed past-wheezers both without AHR and with AHR and past-asthmatics in young atopic 
adults who are currently asymptomatic. The serum levels were transferred to a logarithmic 
function to produce normally skewed data. Higher total IgE levels in serum were observed 
in the self-reported past-wheezers with AHR compared with those without AHR. Never-
wheezers, subjects with no past history of wheezing symptoms; Self-reported past-
wheezers, subjects with a childhood/adolescent history of wheezing symptoms but without 
an asthma diagnosis; Past-asthmatics, subjects who had a history of asthma at their 
school-ages diagnosed by pediatric specialists but had no wheeze symptoms without use 
of any asthma medication for at least 3 preceding years; AHR, airway hyperresponsive-
ness; IgE, immunoglobulin E.
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wheezers and self-reported past-wheezers without
AHR (P = 0.027 by Kruskal-Wallis test, P = 0.033 vs.
never-wheezers and P = 0.027 vs. self-reported past-
wheezers without AHR by Mann-Whitney U-test)
(Fig. 3). Significant higher counts of eosinophils were
also observed in self-reported past-wheezers with
AHR compared with those without AHR and never-
wheezers (P = 0.025 vs. self-reported past-wheezers
without AHR and P = 0.043 vs. never-wheezers by
Mann-Whitney U-test). All participants had above-
normal serum total IgE or specific IgE levels. While
the mean level of serum total IgE in past-asthmatics
was not significantly different from other subject
groups, higher levels were observed in the self-
reported past-wheezers with AHR compared with
those without AHR (P = 0.048 by one-way ANOVA,
P = 0.017 by post-hoc test) (Fig. 4). In particular, the
levels of IgE specific to house dust mites was signifi-
cantly higher in past-asthmatics than in self-reported
past-wheezers without AHR and never-wheezers (P =
0.015 by Kruskal-Wallis test, P = 0.009 vs. self-
reported past-wheezers without AHR and P = 0.020
vs. never-wheezers by Mann-Whitney U-test) (Fig. 5).
Higher median value was observed in self-reported
past-wheezers with AHR compared with those with-
out AHR (P = 0.044 by Mann-Whitney U-test).
DISCUSSION
In the present study, we sought to identify the clinical
characteristics of young atopic adult self-reported
past-wheezers, particularly those with AHR, by com-
parison to those of never-wheezers and past-
asthmatics. Reduced spirometric values and in-
creased atopic blood parameters were found in past-
asthmatics compared with the age-matched never-
wheezers and self-reported past-wheezers without
AHR. Similarly, self-reported past-wheezers with AHR
had lower spirometric function levels and higher al-
lergen sensitisation levels than those without AHR.
To date, many prospective studies have docu-
mented the time course and outcomes of wheezing
disorders and revealed that they are highly vari-
able.2,20 In particular, some of children with wheezing
disorders are at risk for impaired lung function
growth; subsequently at an increased risk for devel-
oping asthma, even if the clinical symptoms subside
Self-Reported Past Wheeze, AHR and Atopy
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Fig.　5　Serum levels of IgE specifi c to house dust mites obtained from never-wheezers, self-re-
ported past-wheezers both without AHR and with AHR and past-asthmatics in young atopic adults 
who are currently asymptomatic. The horizontal bars represent the median values for each sub-
ject group. Higher levels of the specifi c IgE were observed in the past-asthmatics compared with 
the levels observed in never-wheezers and self-reported past-wheezers without AHR. And the 
self-reported past-wheezers with AHR had increased levels of the specifi c IgE compared with 
those without AHR. Never-wheezers, subjects with no past history of wheezing symptoms; Self-
reported past-wheezers, subjects with a childhood/adolescent history of wheezing symptoms but 
without an asthma diagnosis; Past-asthmatics, subjects who had a history of asthma at their 
school-ages diagnosed by pediatric specialists but had no wheeze symptoms without use of any 
asthma medication for at least 3 preceding years; AHR, airway hyperresponsiveness; IgE, immu-
noglobulin E.
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in adolescence.21 In the present study, we first high-
lighted a group of the self-reported past-wheezers in
atopic young adulthood. We hypothesized that the
clinical features of the population might be intermedi-
ate and diverse between never-wheezers and past-
asthmatics. In fact, the present study demonstrated
that, while spirometric values and blood atopic pa-
rameters did not differ between past-wheezers with-
out AHR and never-wheezers, those with AHR had re-
duced FEV1 and FEF25-75 values (% predicted) and in-
creased levels of eosinophils, total IgE and IgE spe-
cific for house dust mites in the blood similar to those
of past-asthmatics. This observation raises the possi-
bility that the past-wheezers with AHR might form a
distinct subgroup with clinical implications of a possi-
ble risk factor for adult asthma.10,11 Accordingly, the
evidence indicates that attention needs be paid to the
self-reported past-wheezers, in particular those with
AHR, and raises the issue about definition of whom
we should monitor and treat in such intermediate
group.
Although numerous articles have so far debated
the best way to define and classify the disease of
asthma and wheezing disorders for epidemiological
purposes, these works reveal an uncertainty about
the exact features that identify subjects with a clini-
cally important disease rather than respiratory symp-
toms without important sequelae. First, such uncer-
tainty is especially true given that patients have one
or only a few of clinical features of asthma transiently.
For example, previous studies showed that wheezing
symptom alone does not necessarily correlate with
the presence of other asthma characteristics in chil-
dren22; this symptom might also be caused by a tran-
sient airway narrowing or closure resulting from in-
flammation (i.e., following a viral infection), or it
might occur spontaneously as a result of the individ-
ual airway structure, particularly in preschool chil-
dren.23 Second, it appears that this uncertainty might
also arise from a lack of understanding of the com-
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plex relationships among subjective symptoms and
objective parameters that represent the presence of
asthma. For example, while the wheezing symptoms
and reduced spirometric function can be observed in
the absence of AHR in early life,24,25 AHR can develop
even in the absence of symptoms.26-29 Previous longi-
tudinal studies have indicated a negative impact of
‘recent’ wheezing episodes and concomitant AHR on
subsequent FEV1 increases that were observed from
age 8 to 19.7,8,16 In this sense, the present findings
add new evidence because not only ‘recent’ but also a
past history of wheezing episodes in the presence of
AHR could indicate a specific asthma-related pheno-
type in currently asymptomatic young adults with
atopy.
Latent airway inflammation and structural remodel-
ling underlying persistent spirometric abnormalities
were known to be observed in past-asthmatics.12,30,31
Likewise, it is assumed that such pathophysiological
changes might also develop in the airways of the self-
reported past-wheezers with AHR, given their ob-
served clinical similarity to the past-asthmatics.
Higher levels of blood eosinophils and IgE specific to
house dust mites in the past-wheezers might indicate
the presence of such airway changes, though not di-
rectly assessed. Future investigations to illuminate
the pathophysiological determinants of the develop-
ment of self-reported wheezing with AHR by direct
assessment of airway biomarkers might provide a
better picture of the natural history of asthma, wheez-
ing disorders and AHR.
There are some potential limitations to the present
findings. First, recall bias could possibly have no
small effect on the participant responses to interview
questions about the presence or absence of past
wheezing episodes per se in the present study.32 Sec-
ond, the study could not fully reveal alone whether
the phenotype (with AHR) really constitutes a risk
factor of future onset of asthma because the self-
reported past-wheezers with or without AHR were
not prospectively evaluated in the present study.
Thus, prospective studies will also be needed to ex-
amine the risk of adult-onset asthma, the rate of de-
cline in spirometric function and the change in preva-
lence and severity of AHR in young adult self-
reported past-wheezers with AHR compared with
age-matched counterpart with a childhood history of
asthma. However, the present study at least demon-
strated that self-reported past-wheezers with AHR ex-
hibited reduced spirometric function during asympto-
matic young adulthood and that, if the disease ap-
pears later, it impacts these individuals severely (with
lower pulmonary function evident even at the initial
stage of the disease).
In summary, the present findings reveal evidence
that the population of self-reported past-wheezers
might include various clinical entities and underscore
the significance of this population in that a past his-
tory of wheezing symptoms in childhood and adoles-
cence are useful for clinically categorising young
adult individuals with asthma-related conditions. To
characterise the intermediate clinical conditions,
which lie on the broad continuum between complete
health and severe disease in terms of asthma-related
conditions, such undiagnosed self-reported wheezing
symptoms might provide useful information for defin-
ing asthma and understanding the natural history of
asthma-related subtypes.
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